The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period.
A companion diagnostics test is done to understand which patient can gain benefits from a specific drug or decide upon the kind of dosage that should be prescribed. All of this, on the basis of a patient's clinical diagnosis, which offers required evidence for the successful and harmless utilization of an equivalent biological or drug product to treat the medical issue. These can also be referred to as medical instruments that help doctors in electing which dosage or treatment is sufficient for patients and suits to their necessity.
The growth of research and development activities in the genetic sciences and biomarkers leads to new drug development mechanisms, dominated by companion diagnostics in the personalized medicine phase. Moreover, the development and usage of companion diagnostics have considerably improved the knowledge of the molecular causes of illnesses, the identification of many biomarkers and the development of targeted treatment.
Based on Technology, the market is segmented into Immunohistochemistry, Polymerase chain reaction (PCR), Next generation sequencing (NGS), In Situ Hybridization, and Other Technology. Based on Indication, the market is segmented into Oncology, Neurology and Other Indications. Further based on Cancer Type, the Oncology market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer and Other Cancer Type.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.5 Methodology for the research
Chapter 2. Market Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Companion Diagnostics Market by Technology
3.1 Global Immunohistochemistry Market
3.2 Global Polymerase chain reaction (PCR) Market
3.3 Global Next generation sequencing (NGS) Market
3.4 Global In Situ Hybridization Market
3.5 Global Other Technology Market
Chapter 4. Global Companion Diagnostics Market by Indication
4.1 Global Oncology Companion Diagnostics Market
4.2 Global Companion Diagnostics Market by Cancer Type
4.2.1 Global Breast Cancer Companion Diagnostics
4.2.2 Global Colorectal Cancer Companion Diagnostics
4.2.3 Global Lung Cancer Companion Diagnostics
4.2.4 Global Blood Cancer Companion Diagnostics
4.2.5 Global Other Cancer Type Companion Diagnostics Market
4.3 Global Neurology Companion Diagnostics Market
4.4 Global Other Indications Companion Diagnostics Market
Chapter 5. Global Companion Diagnostics Market by Region
Chapter 6. Company Profiles
- Agilent Technologies, Inc.
- Almac Group
- ARUP Laboratories, Inc.
- Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Hologic, Inc.
- Novartis AG
- Illumina, Inc.
- Qiagen N.V.
For more information about this report visit https://www.researchandmarkets.com/r/7tt9ut